Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 24 results for "dr lal pathlabs"

Dr Lal Pathlabs' strong brand and network keep it in the pink ...

Dr Lal Pathlabs is Business Standard Star SME of the Year 2016 Business Standard, 3 days ago
Star SME: The right diagnostics Business Standard, 1 week ago

4 images for dr lal pathlabs

Investing.com, 1 month ago
Outlookbusiness.com, 4 months ago
Business Standard India, 7 months ago
VC Circle, 6 months ago

Westbridge Crossover sells 12.91 lakh shares of Dr Lal PathLabs

On March 01, 2017 Westbridge Crossover Fund LLC sold 12,91,920 shares of Dr Lal PathLabs.
 Money Control3 weeks ago Wagner sells 12.25 lakh shares of Dr Lal PathLabs  Money Control1 month ago Buy Dr. Lal Pathlabs; target of Rs 1230: Edelweiss  Money Control1 month ago Dr Lal Pathlabs allots 2.85 lakh equity shares  Business Standard2 months ago

Westbridge sells 1.56% stake in Dr Lal PathLabs for Rs 123cr

Westbridge Crossover today sold 1.56 per cent stake in diagnostic chain Dr Lal PathLabs for nearly 123 crore through an open market transaction.
 DNA3 weeks ago Dr Lal PathLabs reports net profit of Rs 31 crore in Q3 FY17  DNA1 month ago Dr. Lal Pathlab Q3 PAT may dip 20% to Rs 42 cr: ICICI Securities  Money Control2 months ago

Gradual sales recovery for Dr Lal PathLabs

December quarter could come under pressure, but growth set to improve from March quarter
 Business Standard2 months ago Compass: Gradual sales recovery for Dr Lal PathLabs  Business Standard2 months ago

Dr. Lal PathLabs' independent director Murugan Rajaram Pandian resigns

Dr. Lal PathLabs Ltd has informed BSE that the Company has, on February 14, 2017 received, an intimation dated February 13, 2017 from Dr. Murugan Rajaram Pandian, Independent Director, tendering his resignation from the Company with immediate effect.
 Money Control1 month ago Dr. Lal PathLabs: Outcome of board meeting  Money Control1 month ago Board of Dr Lal Pathlabs to consider December quarter results and interim dividend  Business Standard2 months ago

Volumes jump at Navkar Corporation counter

Mafatlal Industries, Dr. Lal PathLabs, Monsanto India and Atul are among the other stocks to see a surge in volumes on BSE today, 20 January 2017.
 Business Standard2 months ago

Results to watch out for! Glenmark, Marico, Godrej Properties in focus

The results which are expected today are Glenmark, Godrej Properties, Marico, HCC, Dr Lal PathLabs, Aegis Logistics, Astrazeneca Pharma, TeamLease, Godfrey Phillips, Vijaya Bank.
 India Infoline1 month ago

Eris Lifesciences files IPO papers with Sebi

Pharmaceutical firm Eris Lifesciences has filed draft papers with capital market regulator Sebi to float an initial public offering. The IPO will see sale of 28,875,000 equity shares by the existing shareholders. "The company expects that listing of the ...
 Business Standard1 month ago

Paytm now accepted across major hospital chains in India

Paytm announced on Monday that it has partnered with several hospital chains to expand its acceptance across the country's healthcare sector to assist millions of consumers as they can now use its cashless payment solution to pay for their medical expenses in ...
 Business Standard2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less